BOSTON SCIENTIFIC CORP (BSX)
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Address
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, MA 01752-1234
Founded
1979
Number of Employees
48,000
Website
http://www.bostonscientific.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s ) |
- | - | - | - | - | - | $534,287 | - | - | - | - | $534,287 |
| Average Price | - | - | - | - | - | - | $33.98 | - | - | - | - | $33.98 |
| # Shares Purchased | - | - | - | - | - | - | 15,723,578 | - | - | - | - | 15,723,578 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | - | - | 144.3% | - | - | - | - | 144.3% |
| S&P 500 Return to Date | - | - | - | - | - | - | 74.8% | - | - | - | - | 74.8% |
| Excess Total Return | - | - | - | - | - | - | 69.4% | - | - | - | - | 69.4% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | - | - | 83% | - | - | - | - | 90% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at BSX make a trade.
Creating a free account takes less than one minute